Abstract
Protein complex formation depends on the interplay between preorganization and flexibility of the binding epitopes involved. The design of epitope mimetics typically focuses on stabilizing a particular bioactive conformation, often without considering conformational dynamics, which limits the potential of peptidomimetics against challenging targets such as transcription factors. We developed a peptide-derived inhibitor of the NF-Y transcription factor by first constraining the conformation of an epitope through hydrocarbon stapling and then fine-tuning its flexibility. In the initial set of constrained peptides, a single non-interacting α-methyl group was observed to have a detrimental effect on complex stability. Biophysical characterization revealed how this methyl group affects the conformation of the peptide in its bound state. Adaption of the methylation pattern resulted in a peptide that inhibits transcription factor assembly and subsequent recruitment to the target DNA.
Original language | English |
---|---|
Pages (from-to) | 17351-17358 |
Number of pages | 8 |
Journal | Angewandte Chemie. International Edition |
Volume | 58 |
Issue number | 48 |
Early online date | 20 Sept 2019 |
DOIs | |
Publication status | Published - 25 Nov 2019 |
Bibliographical note
© 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA.Funding
We acknowledge the MPI Dortmund SLS team for collecting datasets and thank Dr. Matthias Mueller, Dr. Arsen Petrovic and Dr. Eyad Fansa for discussions on data processing. This work was supported by the Deutsche Forschungsgemeinschaft (DFG; Emmy Noether program GR3592/2-1), the European Reasearch Council (ERC; ERC starting grant, no. 678623) and Regione Campania—POR Campania FESR 2014/2020 “Combattere la resistenza tumorale: piattaforma integrata multidisciplinare per un approccio tecnologico innovativo alle oncoterapie—Campania Oncoterapie” (B61G18000470007). We also thank Astra Zeneca, Bayer CropScience, Bayer Health-Care, Boehringer Ingelheim, Merck KGaA, and the Max Planck Society for their support.
Funders | Funder number |
---|---|
Bayer Health-Care | |
AstraZeneca | |
Boehringer Ingelheim | |
Bayer CropScience | |
Merck KGaA | |
Horizon 2020 Framework Programme | 678623 |
European Research Council | |
Deutsche Forschungsgemeinschaft | GR3592/2-1 |
Regione Campania | B61G18000470007 |
Max-Planck-Gesellschaft |
Keywords
- constrained peptides
- peptide inhibitors
- protein structure
- protein–DNA interactions
- protein–protein interactions